Clinical Trial

Effect of a Multi-strain Probiotic on Recurrent Vulvovaginal Candidiasis

Study acronym: PROVELIA
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated November 7, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
This study evaluates the effect of a multi-strain probiotic on the risk of recurrence and severity of symptoms in females with recurrent vulvovaginal candidiasis (R-VVC).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-25.
Status change: Not Yet Recruiting → Recruiting 2024-11-05
Trial Details
NCT Number NCT06480604
Lead Sponsor The Archer-Daniels-Midland Company
Collaborators: Vedic Lifesciences Pvt. Ltd.
Conditions Vulvovaginal Candidiasis
Enrollment 126 participants
Start Date 2024-10-15
Primary Completion 2025-07 (estimated)
Study Completion 2025-07 (estimated)
Updated on ClinicalTrials.gov 2024-11-07